Rock Springs Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-550,000
Closed -$15.4M – 141
2022
Q1
$15.4M Sell
550,000
-390,000
-41% -$10.7M 0.39% 66
2021
Q4
$25.7M Sell
940,000
-280,000
-23% -$7.59M 0.59% 55
2021
Q3
$33.2M Hold
1,220,000
– – 0.7% 48
2021
Q2
$20.9M Buy
1,220,000
+139,800
+13% +$2.62M 0.41% 74
2021
Q1
$22.6M Buy
1,080,200
+380,200
+54% +$8.77M 0.49% 68
2020
Q4
$16M Buy
700,000
+200,000
+40% +$3.81M 0.34% 91
2020
Q3
$8.15M Hold
500,000
– – 0.21% 111
2020
Q2
$6.77M Hold
500,000
– – 0.19% 120
2020
Q1
$5.92M Sell
500,000
-300,000
-38% -$6.65M 0.25% 91
2019
Q4
$19.9M Sell
800,000
-72,500
-8% -$1.47M 0.63% 63
2019
Q3
$14.8M Buy
872,500
+82,500
+10% +$1.5M 0.59% 57
2019
Q2
$18M Buy
790,000
+325,000
+70% +$8.77M 0.65% 56
2019
Q1
$14.9M Hold
465,000
– – 0.58% 57
2018
Q4
$13.1M Buy
465,000
+5,000
+1% +$146K 0.62% 53
2018
Q3
$13.2M Buy
460,000
+50,000
+12% +$1.5M 0.48% 67
2018
Q2
$15.4M Hold
410,000
– – 0.59% 66
2018
Q1
$16.1M Buy
410,000
+65,000
+19% +$2.37M 0.69% 52
2017
Q4
$11.2M Hold
345,000
– – 0.51% 68
2017
Q3
$10.7M Hold
345,000
– – 0.5% 68
2017
Q2
$9.64M Hold
345,000
– – 0.49% 64
2017
Q1
$5.92M Hold
345,000
– – 0.34% 81
2016
Q4
$4.17M Hold
345,000
– – 0.28% 85
2016
Q3
$5.46M Buy
345,000
+5,000
+1% +$75.3K 0.34% 84
2016
Q2
$4.4M Hold
340,000
– – 0.33% 88
2016
Q1
$6.46M Buy
340,000
+2,707
+0.8% +$49K 0.54% 61
2015
Q4
$7.59M Buy
337,293
+99,793
+42% +$1.97M 0.58% 61
2015
Q3
$5.56M Buy
237,500
+62,500
+36% +$1.72M 0.45% 73
2015
Q2
$5.01M Buy
+175,000
New +$4.59M 0.37% 89

Rock Springs Capital Management's XENT Position: Q2 2022 in Review

Rock Springs Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 550,000 shares — an estimated $15.4M sold.

Rock Springs Capital Management first reported a position in XENT in Q2 2015 and held it in 28 quarters. The position peaked at $33.2M in Q3 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Rock Springs Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Rock Springs Capital Management sold 550,000 Intersect ENT, Inc shares in Q2 2022, an estimated $15.4M.
  • Rock Springs Capital Management first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 28 quarters.
  • Rock Springs Capital Management's Intersect ENT, Inc position peaked at $33.2M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Rock Springs Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.